EZZ Life Science Holdings Limited
ASX:EZZ.AX
3.5 (AUD) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 66.443 | 37.143 | 15.022 | 22.287 | 17.315 | 11.187 |
| Cost of Revenue
| 17.152 | 9.94 | 7.514 | 9.828 | 13.753 | 6.827 |
| Gross Profit
| 49.291 | 27.203 | 7.509 | 12.459 | 3.562 | 4.361 |
| Gross Profit Ratio
| 0.742 | 0.732 | 0.5 | 0.559 | 0.206 | 0.39 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 1.145 | 0.896 | 0.682 | 0.296 | 0.9 |
| Selling & Marketing Expenses
| 0 | 20.558 | 2.969 | 7.843 | 1.554 | 1.969 |
| SG&A
| 39.574 | 22.588 | 3.865 | 8.526 | 2.082 | 3.183 |
| Other Expenses
| 0 | 0.259 | 0.141 | 0.175 | 0 | 0 |
| Operating Expenses
| 39.574 | 22.588 | 5.866 | 9.886 | 2.082 | 3.183 |
| Operating Income
| 9.717 | 4.615 | 1.784 | 2.748 | 1.48 | 1.177 |
| Operating Income Ratio
| 0.146 | 0.124 | 0.119 | 0.123 | 0.085 | 0.105 |
| Total Other Income Expenses Net
| 0.243 | 0.285 | 0.141 | 0.175 | 0.67 | -0 |
| Income Before Tax
| 9.959 | 4.901 | 1.78 | 2.737 | 2.15 | 1.177 |
| Income Before Tax Ratio
| 0.15 | 0.132 | 0.118 | 0.123 | 0.124 | 0.105 |
| Income Tax Expense
| 2.995 | 1.271 | 0.467 | 0.706 | 0.564 | 0.354 |
| Net Income
| 6.964 | 3.63 | 1.312 | 2.031 | 1.586 | 0.824 |
| Net Income Ratio
| 0.105 | 0.098 | 0.087 | 0.091 | 0.092 | 0.074 |
| EPS
| 0.16 | 0.085 | 0.031 | 0.048 | 0.038 | 0.02 |
| EPS Diluted
| 0.16 | 0.085 | 0.031 | 0.048 | 0.038 | 0.02 |
| EBITDA
| 10.108 | 4.797 | 1.903 | 2.873 | 1.626 | 1.181 |
| EBITDA Ratio
| 0.152 | 0.129 | 0.127 | 0.129 | 0.094 | 0.106 |